We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Endobronchial Valves Significantly Improve Emphysema

By HospiMedica staff writers
Posted on 24 Sep 2007
A new study has found that an implantable endobronchial valve significantly improves lung function measures and quality of life for patients with emphysema. More...


The International Endobronchial Valve for Emphysema PalliatioN Trial (VENT) was conducted between December 2004 and April 2006, involving 321 patients with severe heterogeneous emphysema in 31 centers across the United States and Europe. The patients were randomly assigned to the treatment group or a control group in a 2:1 ratio. Primary study endpoints were forced expiratory volume in 1 second [FEV1] and the 6-minute walk test, evaluated at 6 months after treatment.

The study findings showed that among the 220 treated patients who received valve placements, FEV1 had improved by 5.8%, whereas for the 101 controls, FEV1 declined by 0.6%. For the other primary study endpoint, the 6-minute walk test, treated patients improved their distance by 1.7% (about 15 meters) after 6 months, whereas the controls' distance declined by 4.0%. Most secondary endpoints, including quality-of-life scales, also significantly improved. The study results were presented at the 17th Annual Congress of the European Respiratory Society, held during September 2007 in Stockholm (Sweden).

"The underlying logic behind both valve placements and surgical resection is to ‘shrink the footballs' in the chest that do nothing but take up space,” said principal investigator Frank Sciurba, M.D., of the University of Pittsburgh Medical Center (PA, USA). "Inflated, diseased lung saps air from functioning lung and pushes the lungs down too far into the abdomen, where they impair normal mechanical function of the diaphragm.”

The endobronchial valve is designed to block airflow to a diseased region of an emphysematous lung, thereby conferring the benefits of lung volume reduction surgery (LVRS) without the risks of major surgery. The one-way valve allows gas to vent from the isolated lung section during exhalation but prevents air from refilling the area during inhalation. The valve also allows mucus to be expelled, which reduces the chance of infection. Most patients require three valves to be implanted to isolate their most damaged lung section.


Related Links:
University of Pittsburgh Medical Center

Gold Member
Neonatal Heel Incision Device
Tenderfoot
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
POC Respiratory/Sore Throat Test
BIOFIRE SPOTFIRE (R/ST) Panel
Rapid Sepsis Test
SeptiCyte RAPID
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.